RNA · Regulatory biology · Artificial intelligence
Foundry advances drug discovery and development. Eigen Insights turns biological data and expertise into AI training, research tools and patient support.
Explore the scienceKRAS · RAF1 · MAP2K1 · MAPK1 · ELK1
Drag to rotate · Swipe sideways on touch
A curved three-dimensional network showing selected gene products in the MAPK, PI3K–AKT and WNT pathways. Choose a pathway to highlight its schematic associations. The selected genes are listed below the pathway buttons.
When the map is focused, arrow keys rotate, plus and minus zoom, Home resets the view, Space plays or pauses motion, and N explores the next gene. On touch screens, swipe horizontally to rotate; vertical swipes and pinch gestures remain available for page scrolling and browser zoom.
Illustrative human pathway map. Connections summarize pathway associations; geometry and motion carry no measured or causal meaning.
MAPK pathway referenceWe begin with the biology of disease. Foundry connects target hypotheses, drug assets and experimental validation to identify programs worth advancing.
Explore FoundryDefine the state and unmet need.
Examine the mechanism and evidence.
Assess exposure, safety and development fit.
Test the assumptions that determine what advances.
Foundry / Pipeline
Oncology programs built around assets with prior human PK data.
Evidence reviewed
Treatment-persistent prostate cancer.
Treatment-persistent colorectal cancer.
Bars show prior asset development reaching Phase 1. Eigen’s current work in the proposed indications is asset evaluation and validation preparation.
Eigen Insights brings together our data and AI training business, ORIGIN, and Paladin.
Explore Eigen InsightsResearch
Contact Eigen Bio
Discuss a therapeutic program, an AI data project, an ORIGIN evaluation or a research partnership.
